148 related articles for article (PubMed ID: 23731891)
1. Deterioration in donepezil-induced PR prolongation after a coadministration of memantine in a patient with Alzheimer's disease.
Igeta H; Suzuki Y; Motegi T; Sasaki A; Yokoyama Y; Someya T
Gen Hosp Psychiatry; 2013; 35(6):680.e9-10. PubMed ID: 23731891
[TBL] [Abstract][Full Text] [Related]
2. Comparison of adverse drug reactions with donepezil versus memantine: analysis of the French Pharmacovigilance Database.
Babai S; Auriche P; Le-Louët H
Therapie; 2010; 65(3):255-9. PubMed ID: 20699079
[TBL] [Abstract][Full Text] [Related]
3. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
[No Abstract] [Full Text] [Related]
4. Cardiovascular pharmacodynamics of donepezil hydrochloride on the PR and QT intervals in patients with dementia.
Igeta H; Suzuki Y; Tajiri M; Someya T
Hum Psychopharmacol; 2014 May; 29(3):292-4. PubMed ID: 24615803
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine.
Doody RS; Geldmacher DS; Farlow MR; Sun Y; Moline M; Mackell J
Dement Geriatr Cogn Disord; 2012; 33(2-3):164-73. PubMed ID: 22572767
[TBL] [Abstract][Full Text] [Related]
6. Use of memantine for the treatment of dementia.
Lo D; Grossberg GT
Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced lupus erythematosus associated with donepezil: a case report.
Manzo C; Putignano S
Age Ageing; 2015 Nov; 44(6):1062-3. PubMed ID: 26420637
[TBL] [Abstract][Full Text] [Related]
8. Pain with donepezil.
Kuloor CB; Puranik A
Age Ageing; 2006 Nov; 35(6):639-40. PubMed ID: 16820527
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
[TBL] [Abstract][Full Text] [Related]
10. [Symptomatic sinus bradycardia associated with donepezil].
Calvo-Romero JM; Ramos-Salado JL
Rev Neurol; 1999 Jun 1-15; 28(11):1070-2. PubMed ID: 10390778
[TBL] [Abstract][Full Text] [Related]
11. A case of donepezil-related torsades de pointes.
Kitt J; Irons R; Al-Obaidi M; Missouris C
BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26438681
[TBL] [Abstract][Full Text] [Related]
12. Memantine and donepezil: a fixed drug combination for the treatment of moderate to severe Alzheimer's dementia.
Owen RT
Drugs Today (Barc); 2016 Apr; 52(4):239-48. PubMed ID: 27252988
[TBL] [Abstract][Full Text] [Related]
13. Donepezil and athetosis in an elderly patient with Alzheimer's disease.
Tanaka M; Yokode M; Kita T; Matsubayashi K
J Am Geriatr Soc; 2003 Jun; 51(6):889-90. PubMed ID: 12757588
[No Abstract] [Full Text] [Related]
14. Higher-dose (23 mg/day) donepezil formulation for the treatment of patients with moderate-to-severe Alzheimer's disease.
Christensen DD
Postgrad Med; 2012 Nov; 124(6):110-6. PubMed ID: 23322144
[TBL] [Abstract][Full Text] [Related]
15. Extrapyramidal side-effect due to drug combination of risperidone and donepezil.
Liu HC; Lin SK; Sung SM
Psychiatry Clin Neurosci; 2002 Aug; 56(4):479. PubMed ID: 12109969
[No Abstract] [Full Text] [Related]
16. Urinary incontinence: an unrecognised adverse effect with donepezil.
Hashimoto M; Imamura T; Tanimukai S; Kazui H; Mori E
Lancet; 2000 Aug; 356(9229):568. PubMed ID: 10950240
[TBL] [Abstract][Full Text] [Related]
17. Memantine: new preparation. Poor evaluation and uncertain benefit in Alzheimer's disease.
Prescrire Int; 2003 Dec; 12(68):203-5. PubMed ID: 14986682
[TBL] [Abstract][Full Text] [Related]
18. Donepezil for Alzheimer's disease.
Benjamin B; Burns A
Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
[TBL] [Abstract][Full Text] [Related]
19. Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease.
Salloway S; Mintzer J; Cummings JL; Geldmacher D; Sun Y; Yardley J; Mackell J
Am J Alzheimers Dis Other Demen; 2012 Sep; 27(6):421-32. PubMed ID: 22930699
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
